Equities

Hubei Jumpcan Pharmaceutical Co Ltd

600566:SHH

Hubei Jumpcan Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)31.00
  • Today's Change0.26 / 0.85%
  • Shares traded9.32m
  • 1 Year change+16.06%
  • Beta--
Data delayed at least 15 minutes, as of Nov 05 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

HUBEI JUMPCAN PHARMACEUTICAL CO., LTD., formerly Hubei Hongcheng General Machinery Co., Ltd., is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company's products include heat-clearing and detoxifying series, digestive system series, pediatric series, breathing series, cardiovascular series and gynecology series. Its pharmaceuticals consist of tablets, mixtures, injections, capsules, granules and sprays, among others. The Company mainly distributes its products within domestic markets.

  • Revenue in CNY (TTM)8.92bn
  • Net income in CNY2.78bn
  • Incorporated1997
  • Employees5.23k
  • Location
    Hubei Jumpcan Pharmaceutical Co LtdBaotawan, Daqing West Road, Taixing CityTAIZHOU 225441ChinaCHN
  • Phone+86 52 389719161
  • Fax+86 52 389719009
  • Websitehttps://www.jumpcan.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nanjing King-Frind Bchmcl Phrmctcl C Ltd3.88bn-422.97m24.06bn1.45k--3.84--6.20-0.3269-0.32692.433.880.37740.50124.352,672,280.00-4.128.97-5.7613.1541.0045.59-10.9120.121.51-2.960.26926.335.8918.25-117.37--38.3213.75
Shanghai Junshi Biosciences Co Ltd1.79bn-1.80bn25.67bn2.53k--4.80--14.36-1.83-1.831.816.260.15930.84064.29695,986.10-17.55-18.87-21.98-23.1169.0769.13-110.18-88.411.75-67.730.3065--3.38248.394.38--8.36--
Zhejiang Huahai Pharmaceutical Co., Ltd.9.35bn1.14bn27.35bn8.22k24.003.11--2.930.77720.77726.345.990.49221.023.511,137,186.006.015.678.378.0761.9760.5212.2111.610.79196.250.454133.550.519910.28-28.8850.517.21--
Kangmei Pharmaceutical Co Ltd5.21bn255.55m28.01bn4.41k109.073.98--5.370.01850.01850.37660.50790.36261.452.551,182,457.001.80-17.602.77-32.2420.63-72.784.95-101.190.8398--0.0346--16.60-22.17103.81-22.83-53.51--
Hubei Jumpcan Pharmaceutical Co Ltd8.92bn2.78bn28.33bn5.23k10.152.01--3.183.033.039.7115.270.51353.084.601,706,101.0016.0416.2320.6820.8878.3682.6431.2324.423.55--0.102441.767.326.0230.0410.83-14.701.11
Gan & Lee Pharmaceuticals2.95bn580.86m29.00bn4.48k49.372.59--9.840.97730.97734.9718.650.25580.84588.94657,602.005.048.305.408.8372.9285.3919.7126.446.77--0.000513.6552.311.78177.37-18.301.50--
Bluestar Adisseo Co14.95bn1.09bn30.98bn2.73k28.421.96--2.070.40640.40645.575.900.68875.188.015,466,479.005.035.286.076.9429.2030.317.308.761.167.830.110521.81-9.262.92-95.82-43.752.74-19.09
Xiamen Amoytop Biotech Co Ltd2.60bn740.69m31.68bn1.96k42.7713.99--12.211.821.826.385.571.080.89286.181,324,099.0030.7317.9635.9021.0292.7190.4828.5419.173.60--0.004426.9537.5536.1993.52103.2881.61--
Data as of Nov 05 2024. Currency figures normalised to Hubei Jumpcan Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

3.85%Per cent of shares held by top holders
HolderShares% Held
Zhong Ou Asset Management Co., Ltdas of 30 Jun 20247.29m0.80%
China Southern Asset Management Co., Ltd.as of 30 Jun 20245.47m0.60%
Ping An Fund Management Co., Ltd.as of 30 Sep 20234.67m0.51%
China Asset Management Co., Ltd.as of 30 Jun 20244.29m0.47%
China Universal Asset Management Co., Ltd.as of 30 Jun 20242.46m0.27%
Penghua Fund Management Co., Ltd.as of 30 Jun 20242.43m0.27%
Everbright PGIM Fund Management Co. Ltd.as of 30 Jun 20242.39m0.26%
First Seafront Fund Management Co., Ltd.as of 30 Jun 20242.38m0.26%
GF Fund Management Co., Ltd.as of 30 Jun 20241.98m0.22%
Taikang Asset Management Co. Ltd.as of 30 Jun 20241.88m0.21%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.